Option Care Health Reports Mixed Q1 2026 Results Amid CID Portfolio Reset
Option Care Health reported mixed first-quarter results in 2026, with growth in the acute portfolio offset by a significant reset in its Chronic Inflammatory Disease (CID) segment. The company revised full-year revenue guidance downward to $5.675 billion–$5.775 billion due to lower patient retention and an unfavorable therapy mix.
Tickers: $OPCH
Topics: earnings guidance operational performance revenue segment performance